Clinical Trial Update: A Study Assessing the REG1 Anticoagulation System Compared Heparin in Subjects With Acute Coronary Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the REG1 Anticoagulation System versus heparin in patients with acute coronary syndrome; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Heparin (unfractionated heparin)
• REG1 Anticoagulation System (REG1)

Snippet

Sponsor: Regado Biosciences, Inc. | Conditions: Acute Coronary Syndrome (ACS) | Phase 2 | Status: COMPLETED